Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity
Author:
Funder
Gilead
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1222380
Reference11 articles.
1. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia
2. MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia
3. PI3K/AKT Pathway Is Activated By MYD88 L265P and Use Of PI3K-Delta Inhibitors Induces Robust Tumor Cell Killing In Waldenstrom’s Macroglobulinemia
4. PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia;Current Hematologic Malignancy Reports;2024-07-06
2. The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia;Hematology/Oncology Clinics of North America;2023-08
3. BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia;Hemato;2023-04-13
4. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies;International Journal of Molecular Sciences;2022-09-22
5. SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia;Clinical Lymphoma Myeloma and Leukemia;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3